GlassScriptPhysician profile
Nathan Brian Payne
NPI 1760845473
$10,004.19
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,695 · 2020: $1,590 · 2021: $4,413 · 2022: $2,016 · 2023: $271 · 2024: $20.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,992.13 | 2021 | |
| Sequoia Surgical, INC. | $2,468.06 | 2020-2021 | |
| Pinnacle, INC | $1,392.00 | 2019 | |
| Evolution Surgical, INC | $1,287.73 | 2022-2023 | |
| Abbvie INC. | $354.66 | 2021-2023 | |
| Musculoskeletal Transplant Foundation INC. | $314.78 | 2020-2022 | |
| Organogenesis INC. | $223.31 | 2019-2023 | Puraply |
| Stryker Corporation | $219.02 | 2019-2022 | |
| Treace Medical Concepts, INC. | $191.54 | 2022 | |
| Orthofix Medical, INC. | $115.56 | 2022 | |
| Bioventus LLC | $99.09 | 2019 | |
| Kerecis Limited | $70.36 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Alfasigma USA, INC. | $51.23 | 2021-2022 | |
| Paragon 28, INC. | $39.71 | 2021-2022 | |
| Depuy Synthes Sales INC. | $35.30 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medela LLC | $26.86 | 2020 | |
| Heron Therapeutics, INC. | $23.27 | 2022 | |
| Paratek Pharmaceuticals, INC. | $23.15 | 2019 | |
| Arthrosurface Incorporated | $21.23 | 2020 | |
| Smith+Nephew, INC. | $20.78 | 2022 | |
| Solventum Corporation | $20.03 | 2024 | Activ.A.C., V.A.C. Dermatac, Kerramax Care |
| Zimvie INC. | $14.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.